Follow The Filings

HLF Herbalife

Herbalife earnings company data as of 4:47 AM ET 10/2

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.73 — —
Rev — — —

Insider trades

Open-market buys and sales by HLF's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HLF insider trades
  • $182K bought by 2 insiders
  • $2.6M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Sophie L'Helias Director
    Buy
    $14K 1,200 shares at $11.31 +1.5% to stake
    Traded Jun 4 Filed Jun 4
  2. Troy Hicks COO
    Sale
    $620K 48,377 shares at $12.81 83% of stake
    Traded May 18–19 Filed May 20
  3. Frank Lamberti Chief Commercial Officer
    Sale
    $1.9M 142,919 shares at $13.52 80% of stake
    Traded May 11–12 Filed May 12
  4. Sophie L'Helias Director
    Buy
    $15K 1,200 shares at $12.87 +1.8% to stake
    Traded Nov 26, 2025–Dec 1, 2025 Filed Dec 1, 2025
  5. Lynda Cloud Director
    Buy
    $152K 17,000 shares at $8.97 +78% to stake
    Traded Nov 18, 2025 Filed Nov 20, 2025

Also filed in the last 12 months, not counted as buying or selling: 17 share withholdings for taxes, 11 stock grants, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 5.02
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,5.02,7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
10-Q
8-K 2.02,5.07,7.01,9.01
8-K 1.01,2.03,2.04,8.01,9.01
SCHEDULE 13G —
SCHEDULE 13G —
8-K 8.01,9.01
8-K 2.02,8.01,9.01
SCHEDULE 13G/A —
DEF 14A PROXY STATEMENT
DEFA14A DEFINITIVE ADDITIONAL MATERIALS

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.